Telomir Pharmaceuticals Gains Membership in Prestigious Russell Indexes
Tuesday, 2 July 2024, 12:30
![Business Insider](https://store.livarava.com/ab2e92bd-3871-11ef-b477-e3c1366536d6.png)
Telomir Pharmaceuticals Included in Russell Indexes
TAMPA, Fla., July 02, 2024 (GLOBE NEWSWIRE) -- Telomir Pharmaceuticals, Inc. (Nasdaq: TELO) ( Telomir or the Company), a pre-clinical-stage pharmaceutical company focusing on innovative therapies, has been added to the Russell 3000 and Russell Microcap Indexes.
- This achievement reflects the growing recognition of Telomir within the investment community.
- The inclusion in these prestigious indexes is a testament to Telomir's strong performance and future growth prospects.
- Telomir Pharmaceuticals is now well-positioned among investors and stakeholders for potential investment opportunities.
Do you want to advertise here? Contact us